Description
Specifications
| Form | Lyophilized powder, single vial |
| Sizes | 10 mg, 20 mg, 30 mg, 60 mg |
| Class | Triple incretin receptor agonist |
| Made in | USA |
| Testing | Third-party identity and purity, every lot |
| GLP-3(R) | C₂₂₁H₃₄₂N₄₆O₆₈ · MW 4731.3 · CAS 2381089-83-2 |
How Is GLP-3(R) Studied?
GLP-3(R) is researched as a triple incretin receptor agonist that activates multiple metabolic signaling receptors at once. Preclinical studies have examined its receptor binding profile and downstream effects on insulin secretion, energy expenditure and lipid metabolism, making it a research tool for studying combined incretin-pathway signaling.
Storage
Store the sealed vial at −20 °C for long-term storage, or 2–8 °C short-term, away from light. Once reconstituted in the lab, keep at 2–8 °C and avoid repeated freeze-thaw cycles. See our storage guide.
FAQ
How is it different from GLP-1(S) and GLP-2(T)?
GLP-1(S) targets a single incretin receptor and GLP-2(T) targets two. GLP-3(R) targets three. See GLP research compounds compared.
Is a Certificate of Analysis available?
Yes. Tap “View Certificate of Analysis” on this page for the current lot’s third-party COA.
Do you provide use or dosing guidance?
No. This product is sold strictly for laboratory research, and orders indicating human or animal use are cancelled.
For laboratory research use only. Not for human consumption.
